Israel Corp chairman steps down, to be vice chair of Teva Pharm
JERUSALEM Dec 10 (Reuters) - Israeli conglomerate Israel Corp said on Tuesday its chairman Amir Elstein will step down at the end of the year after 3-1/2 years in the post.
Elstein, who will continue to be an unpaid advisor to the board of directors, will be replaced by Ron Moskovitz, a director since 2008.
Separately, Teva Pharmaceutical Industries, the world's largest generic drugmaker, said it named Elstein as its vice chairman effective Jan. 1 after Moshe Many resigned for personal reasons.
Israel Corp also said Elstein would remain as chairman of Tower Semiconductor, which is partly owned by the company.